UNSPSC 51121908: Powdered or prepared digitalis leaf

This classification denotes a natural product which US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F1T8QT9U8B (base and leaf), which the Integrated Taxonomic Information System classifies under Taxonomic Serial Number 33582 as a member of Kingdom Plantae, Subkingdom Viridaeplantae, Infrakingdom Streptophyta, Division Tracheophyta, Subdivision Spermatophytina, Infradivision Angiospermae, Class Magnoliopsida, Superorder Asteranae, Order Lamiales, Family Plantaginaceae, Genus Digitalis L. (foxglove), commonly known as foxglove or as here, DIGITALIS.

Figitalis bears the USDA PLANTS Database Identifier DIGIT. European Medicines Agency schedules digitalis in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Indices SUB13579MIG (base) and SUB11904MIG (leaf).

UNSPSC 51121908 Powdered or prepared digitalis leaf (Commodity) encompasses emergency medical and pharmaceutical supply procurement by state and local health agencies, though recent activity shows the code being tagged to broader advanced life support medication solicitations that extend well beyond digitalis preparations. State and local buyers under this code include city fire and rescue departments, state health and human services commissions, and multistate cooperative purchasing alliances. The actual work being solicited spans sealed-bid procurement of specific injectable medications (epinephrine, adenosine, labetalol, diltiazem) for emergency response use, direct-to-manufacturer prescription fulfillment programs at the state level, and generic multi-source pharmaceutical supply agreements for health system distribution across participating jurisdictions. Vendors must comply with FDA requirements, Good Manufacturing Practices, Drug Supply Chain Security Act standards, OSHA Hazard Communication requirements for Safety Data Sheets, and federal accessibility standards including WCAG 2.2 Level AA conformance.

Recent activity spans Florida, Texas, and Minnesota. The City of Tampa Fire Rescue issued an IFB (No. 26P00188) for Advanced Life Support Medications with a response deadline of April 8, 2026, carrying an estimated contract value of $40,000 and offering a 5 percent bid discount for Small Local Business Enterprise participation; the contract term runs one year with options to renew for two additional one-year periods plus up to three unilateral 30-day extensions. The Texas Health and Human Services Commission issued an RFI (No. HHS0017013) in late March 2026 seeking vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program to support self-insured plans and state agencies outside traditional pharmacy benefit manager and group purchasing organization channels. The Minnesota Multistate Cooperative Purchasing Alliance issued an RFP (No. S1070000015802) for Generic Multi Source Pharmaceuticals and OTC Products with a response deadline of March 26, 2026, requiring vendors to distribute through three authorized wholesalers (AmerisourceBergen, Cardinal Health, Morris & Dickson) and maintain $5 million in commercial general liability coverage; the contract term is two years with optional extensions at MMCAP's sole discretion.